Post Profile

Merck drug shines in lung cancer and also works with chemo

COPENHAGEN (Reuters) - Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.
read more


Related Posts

Merck Cancer Drug Shines Against Skin, Lung Cancer

Business & Finance : Forbes: Business

Merck’s immune-boosting cancer drug, Keytruda, bested the standard of care in advanced melanoma, the deadly skin cancer, and showed promising results in non-small cell lung cancer. Based on these data, Merck says it will file an app...

Merck's Keytruda achieves 24 percent response in bladder cancer study

Health : Reuters: Health

(Reuters) - Merck & Co's immunotherapy Keytruda proved effective as an initial treatment for nearly a quarter of patients with advanced bladder cancer too frail for standard cisplatin chemotherapy, according to interim results from ...

Bristol drug flop opens big cancer opportunity: AstraZeneca CEO

Health : Reuters: Health

COPENHAGEN (Reuters) - The failure of Bristol-Myers Squibb's blockbuster Opdivo immunotherapy in previously untreated lung cancer patients has opened up the market for AstraZeneca, its chief executive believes.

Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo

Health : Reuters: Health

(Reuters) - Recent clinical trial results are likely to lead doctors to treat more patients who have a common form of lung cancer with a Merck drug at the expense of a Bristol-Myers Squibb medication at least until more data emerges...

Immunotherapy drug a 'gamechanger' for head and neck cancer

Health : The Guardian: Health

Nivolumab found to extend lives of relapsed patients who had run out of therapy options An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untrea...


Copyright © 2016 Regator, LLC